Healthcare Global Enterprises Limited — PPTs, 24-05-2025: Investor Presentation

1. Financial Highlights:

Revenue rose 16% YoY to ₹2,222.8 Cr, with HCG Centers contributing ₹2,165.1 Cr (up 17%). Adjusted EBITDA margin improved by 20 bps to 17.8%, and EBITDA increased 17% YoY to ₹396.3 Cr. However, profit after tax fell 8% YoY to ₹44.4 Cr due to higher depreciation and finance expenses. Operational volumes showed strength: outpatient footfalls +14%, chemo sessions +12%, and stable radiation therapy utilization (~58%). Operational beds grew to 1,493 with occupancy at 65.7%. Net debt nearly doubled to ₹63.17 Cr (₹31.75 Cr excluding leases), reflecting ongoing capex of ₹20.56 Cr.

2. Strategic Initiatives & Growth Drivers:

Focus remains on brownfield expansions in Bangalore and Mumbai, developing Centers of Excellence featuring new technologies like 5 additional LINACs and robotic surgery suites. Digitization is a key growth lever via an SEO-optimized website and HCG Care App, targeting 25% revenue from digital channels. Investments in genomics and precision medicine aim to improve clinical outcomes and personalization. Enhanced marketing efforts focus on B2B/B2C engagement and increasing international patient inflows.

3. Business Developments:

Growth through acquisition and scaling of emerging sites in South Mumbai, Borivali, and Kolkata continues, with turnaround and profitability now a priority. Milann fertility segment saw revenues decline 14% YoY, with consolidation centered on Bangalore. Recent integrations, especially in Cuttack and Borivali, are driving steady expansion.

4. Market Position & Competitive Advantage:

HCG stands as India’s largest oncology hospital chain with 41 hospitals in 25 cities, leading in 16 of 18 key markets. Its clinical outcomes rival international standards, supported by specialized cancer care, multidisciplinary tumor boards, and advanced technology. Strong oncologist retention and patient-centric care underpin its differentiated positioning and competitive moat.

5. Investor Implications:

Healthy revenue and margin growth combined with a clear capex plan point to positive growth potential. Digitization and improving operational metrics should boost patient acquisition and monetization. Monitoring profitability of emerging centers and acquisition integration is key. Overall, HCG’s scale, clinical excellence, and geographic reach provide a solid foundation for sustained value creation.